
![]() ![]() ![]()
Pharmaceutical LitigationBailey & Galyen is a nationally recognized firm which handles pharmaceutical lawsuits on behalf of clients who have suffered serious injuries from dangerous prescription drugs, dangerous over the counter remedies and preparations and defective medical devices. Latest FDA NewsFDA allows marketing of first A1c test labeled for diagnosing diabetesRead Story FDA expands alert to health care providers about lack of sterility assurance of all sterile drug products from NuVision Pharmacy Read Story FDA seeks preliminary injunction against New York fish manufacturer Read Story FDA approves Simponi to treat ulcerative colitis Read Story FDA approves new drug for advanced prostate cancer Read Story Bailey & Galyen has assisted clients across the nation in the successful litigation of their pharmaceutical and medical device lawsuits. We understand the emotional, medical and legal component of these cases and offer a compassionate, client-focused practice for these matters. When you turn to Bailey & Galyen, you can count on our legal expertise and our commitment to meeting the highest ethical and legal standards in resolving your case effectively and efficiently as possible. We are committed to providing you with close, personalized attention and responsive legal services. Our law firm believes communication is the heart of trusted attorney/client relationships. To that end our lawyers take pride in accessibility. You will never be in the dark concerning the status of your case. You can expect consistent updates and your phone calls are answered promptly, twenty-four hours a day, seven days a week. Legal help is only moments away. Bailey & Galyen is waiting to provide the highest quality representation of injuries sustained from dangerous pharmaceuticals or medical devices. Contact us online or call us at 800-216-2525 to arrange a no-cost, no-obligation consultation.
home |
about the firm |
practice areas |
online resources |
contact us |
news and events |
espanol |
attorney profiles |
|
